Clinical trial
E-MOSAIC: A Multicenter Randomized Controlled Phase III Study of Longitudinal Electronic Monitoring of Symptoms and Syndromes Associated With Advanced Cancer in Patients Receiving Anticancer Treatment in Palliative Intention
NCT00477919 is registered in ClinicalTrials.gov with Swiss Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- E-MOSAIC: A Multicenter Randomized Controlled Phase III Study of Longitudinal Electronic Monitoring of Symptoms and Syndromes Associated With Advanced Cancer in Patients Receiving Anticancer Treatment in Palliative Intention
- Lead sponsor
- Swiss Cancer Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2007
- Completion date
- January 31, 2012
- Enrollment
- 264 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
cancer